XML 41 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 5 - Share-Based Compensation
9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

5.     SHARE-BASED COMPENSATION


The Company measures and recognizes compensation expense for all share-based payments based on the grant-date fair value of those awards. All of the Company’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards.


The Company’s 2001 Equity Incentive Plan provides for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of 1,800,000 class A and 300,000 class B shares of the Company’s common stock. Stock options granted may be either nonqualified or incentive stock options. Stock options vest over one to five years following the date of grant and option terms are generally five to ten years following the date of grant.


The Company’s 2004 Non-Employee Director Stock Plan (the “2004 Director Plan”) is a nonqualified plan that provides for the granting of options with respect to 1,650,000 class A and 275,000 class B shares of the Company’s common stock. The 2004 Director Plan provides for grants of nonqualified stock options to each director of the Company who is not employed by the Company. On the date of each annual meeting of shareholders of the Company, options to purchase 36,000 class A shares and 6,000 class B shares of the Company’s common stock are granted to directors that are re-elected or retained as a director at such meeting. Stock options vest one year following the date of grant and option terms are generally ten years following the date of grant, or three years in the case of termination of the outside director’s service.


The Company’s 2006 Equity Incentive Plan provides for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of 1,800,000 class A and 300,000 class B shares of the Company’s common stock. Stock options granted may be either incentive stock options or nonqualified stock options. Vesting terms vary with each grant and option terms are generally five to ten years following the date of grant.


The Company granted options to purchase 204,166 shares of the Company’s class A common stock and 32,217 shares of the class B common stock during the nine-month period ended September 30, 2014. The Company granted options to purchase 232,344 shares of class A common stock and 38,718 shares of class B common stock during the nine-month period ended September 30, 2013. Options to purchase shares of common stock were granted with exercise prices equal to the fair value of the common stock on the date of grant. The fair value of the stock options granted was estimated using a Black-Scholes valuation model with the following assumptions:


   

2014

Class A

   

2014

Class B

   

2013

Pre-May 2013

Recapitalization

 

Expected dividend yield at date of grant

    1.47 to 1.97%       4.03 to 4.87%       2.26 to 3.46%  

Expected stock price volatility

    27.52 to 32.03%       30.13 to 32.65%       30.34 to 30.51%  

Risk-free interest rate

    1.63 to 2.37%       1.63 to 2.37%       0.55 to 1.07%  

Expected life of options (in years)

    5 to 7       5 to 7       4 to 6  

The risk-free interest rate assumptions were based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was based on historical monthly price changes of the Company’s common stock based on the expected life of the options at the date of grant. The expected life of options is the average number of years the Company estimates that options will be outstanding. The Company considers groups of associates that have similar historical exercise behavior separately for valuation purposes.


The following table summarizes stock option activity under the Company’s 2001 and 2006 Equity Incentive Plans and the 2004 Director Plan for the nine months ended September 30, 2014:


   

Number of
Options

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Terms (Years)

   

Aggregate

Intrinsic

Value

(In thousands)

 

Class A

                               

Outstanding at December 31, 2013

    1,444,845     $ 10.21                  

Granted

    204,166     $ 15.41                  

Exercised

    (110,625 )   $ 6.60             $ 1,268  

Forfeited

    (183,896 )   $ 12.40                  

Outstanding at September 30, 2014

    1,354,490     $ 10.99       6.47     $ 3,947  

Exercisable at September 30, 2014

    817,383     $ 10.58       5.70     $ 2,660  
                                 

Class B

                               

Outstanding at December 31, 2013

    234,802     $ 20.76                  

Granted

    32,217     $ 43.24                  

Exercised

    (18,437 )   $ 14.93             $ 400  

Forfeited

    (30,117 )   $ 23.82                  

Outstanding at September 30, 2014

    218,465     $ 24.14       6.50     $ 3,035  

Exercisable at September 30, 2014

    130,229     $ 21.44       5.75     $ 2,039  

The following table summarizes information regarding non-vested stock granted to associates under the 2006 Equity Incentive Plan for the nine months ended September 30, 2014: 


   

Class A

Shares

Outstanding

   

Class A

Weighted

Average

Grant Date

Fair Value

Per Share

   

Class B Shares

Outstanding

   

Class B

Weighted

Average

Grant Date

Fair Value

Per Share

 

Outstanding at December 31, 2013

    60,609     $ 5.77       10,101     $ 34.65  

Granted

    --       --       --       --  

Vested

    --       --       --       --  

Forfeited

    (23,468 )   $ 6.39       (3,911 )   $ 38.35  

Outstanding at September 30, 2014

    37,141     $ 5.39       6,190     $ 32.31  

As of September 30, 2014, the total unrecognized compensation cost related to non-vested stock awards was approximately $100,000 and is expected to be recognized over a weighted average period of 1.25 years.